{"id":541244,"date":"2019-03-07T11:02:00","date_gmt":"2019-03-07T11:02:00","guid":{"rendered":"https:\/\/www.capgemini.com\/gb-en\/?post_type=client-story&#038;p=541244"},"modified":"2025-03-07T07:50:28","modified_gmt":"2025-03-07T07:50:28","slug":"empowering-patients-to-continue-treatment-for-oab","status":"publish","type":"client-story","link":"https:\/\/www.capgemini.com\/gb-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/","title":{"rendered":"Empowering patients to continue treatment for OAB"},"content":{"rendered":"\n<header class=\"wp-block-cg-blocks-hero-reusable header heroReusable  \"><div class=\"header-bgs\"><picture><source srcset=\"https:\/\/www.capgemini.com\/gb-en\/wp-content\/uploads\/sites\/5\/2022\/05\/invent-hero-12.png?w=2880&amp;quality=70 1x, https:\/\/www.capgemini.com\/gb-en\/wp-content\/uploads\/sites\/5\/2022\/05\/invent-hero-12.png?w=2880&amp;quality=70 2x\" media=\"(min-width: 1500px)\"\/><source srcset=\"https:\/\/www.capgemini.com\/gb-en\/wp-content\/uploads\/sites\/5\/2022\/05\/invent-hero-12.png?w=1440&amp;quality=70 1x, https:\/\/www.capgemini.com\/gb-en\/wp-content\/uploads\/sites\/5\/2022\/05\/invent-hero-12.png?w=2880&amp;quality=70 2x\" media=\"(min-width: 992px)\"\/><source srcset=\"https:\/\/www.capgemini.com\/gb-en\/wp-content\/uploads\/sites\/5\/2022\/05\/invent-hero-12.png?w=1024&amp;quality=70 1x, https:\/\/www.capgemini.com\/gb-en\/wp-content\/uploads\/sites\/5\/2022\/05\/invent-hero-12.png?w=1024&amp;quality=70 2x\" media=\"(min-width: 768px)\"\/><source srcset=\"https:\/\/www.capgemini.com\/gb-en\/wp-content\/uploads\/sites\/5\/2022\/05\/invent-hero-12.png?w=768&amp;quality=70 1x, https:\/\/www.capgemini.com\/gb-en\/wp-content\/uploads\/sites\/5\/2022\/05\/invent-hero-12.png?w=768&amp;quality=70 2x\" media=\"(min-width: 0)\"\/><img decoding=\"async\" src=\"https:\/\/www.capgemini.com\/gb-en\/wp-content\/uploads\/sites\/5\/2022\/05\/invent-hero-12.png\" class=\"header-img header-img-d\" alt=\"\" style=\"object-fit:cover;object-position:50% 50%\" loading=\"eager\"\/><\/picture><\/div><div class=\"heroPictureCardHeaderShape\"><\/div><div class=\"container\"><div class=\"row\"><div class=\"col-md-12\"><div class=\"box\"><div class=\"boxTagWrapper\"><div class=\"tagInfo\"><div><span class=\"box-tag\">Client Stories<\/span><\/div><\/div><\/div><div class=\"box-title\"><h1 data-maxlength=\"34\">Empowering Patients to continue treatment for OAB<\/h1><\/div><div class=\"inner-row-insight download-btn\"><div class=\"col-md-4 downloadFiles addPadding\"><a class=\"button-download--small\" type=\"download\" href=\"https:\/\/www.capgemini.com\/gb-en\/wp-content\/uploads\/sites\/5\/2022\/05\/Empowering-Patients-to-Continue-Treatment-for-OAB-2.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"opens in a new window\"><span>Empowering-Patients-to-Continue-Treatment-for-OAB-2.pdf<\/span><span class=\"type\">897 KB  pdf<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/header>\n\n\n\n<section class=\"wp-block-cg-blocks-intro-para undefined section section--intro\"><div class=\"intro-para\"><div class=\"container\"><div class=\"row\"><div class=\"col-12 col-md-1\"><nav class=\"article-social\"><ul class=\"social-nav\"><li class=\"ip-order-fb\"><a href=\"https:\/\/www.facebook.com\/sharer\/sharer.php?u=https:\/\/www.capgemini.com\/gb-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"opens in a new window\"><i aria-hidden=\"true\" class=\"icon-fb\"><\/i><span class=\"sr-only\">Facebook<\/span><\/a><\/li><li class=\"ip-order-li\"><a href=\"https:\/\/www.linkedin.com\/sharing\/share-offsite\/?url=https:\/\/www.capgemini.com\/gb-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"opens in a new window\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><span class=\"sr-only\">Linkedin<\/span><\/a><\/li><\/ul><\/nav><\/div><div class=\"col-12 col-md-11 col-lg-10\"><h2 class=\"intro-para-title\">THE CHALLENGE<\/h2><\/div><\/div><\/div><\/div><\/section>\n\n\n\n<section class=\"wp-block-cg-blocks-group undefined section section--article-content\"><div class=\"article-main-content\"><div class=\"container\"><div class=\"row\"><div class=\"col-12 col-md-11 col-lg-10 offset-md-1 offset-lg-1\"><div class=\"article-text article-quote-text\">\n<p class=\"wp-block-paragraph\">Finding relief for OAB symptoms can be a long, frustrating journey. The majority of patients cycle through multiple oral medications without satisfactory results. 50% of patients discontinue treatment and many give up on treatment entirely. Patients are often not aware of other treatment options. Hence, patients tend to \u201csettle\u201d for just coping with their symptoms.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-our-solution\">OUR SOLUTION<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Capgemini Invent approached this challenge by creating a multi-platform, unbranded campaign that was designed to engage, motivate, and educate OAB sufferers about their treatment options.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-the-impact\">THE IMPACT<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Our solution proved successful in the following ways:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Averaged 140,568 website visits per week<\/li>\n\n\n\n<li>Averaged 1,758 \u201cFind a Specialist\u201d searches per week<\/li>\n\n\n\n<li>Nearly 700 registrants in the CRM program<\/li>\n\n\n\n<li>48% above average industry open rate for emails<\/li>\n\n\n\n<li>Double the average industry click-through rate<\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":103,"featured_media":541247,"template":"","meta":{"cg_dt_proposed_to":[],"cg_seo_hreflang_relations":"[]","cg_seo_canonical_relation":"","cg_seo_hreflang_x_default_relation":"{\"uuid\":\"6a5fa50d-439b-402b-ae32-bd3aa187dd08\",\"blogId\":\"\",\"domain\":\"\",\"sitePath\":\"\",\"postLink\":\"\",\"postId\":null,\"isSaved\":true,\"isCrossLink\":false,\"hasCrossLink\":false}","cg_dt_approved_content":true,"cg_dt_mandatory_content":false,"cg_dt_notes":"","cg_dg_source_changed":false,"cg_dt_link_disabled":false,"footnotes":"","client_logo_id":0,"client_logo_url":"","primary_term":"","featured_focal_points":""},"tags":[],"brand":[],"service":[],"industry":[],"partners":[],"country":[],"content-group":[],"class_list":["post-541244","client-story","type-client-story","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.7 (Yoast SEO v27.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Empowering patients to continue treatment for OAB - Capgemini UK<\/title>\n<meta name=\"description\" content=\"Client StoriesEmpowering Patients to continue treatment for OABEmpowering-Patients-to-Continue-Treatment-for-OAB-2.pdf897 KB pdf FacebookLinkedinTHE\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.capgemini.com\/gb-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Empowering patients to continue treatment for OAB\" \/>\n<meta property=\"og:description\" content=\"Client StoriesEmpowering Patients to continue treatment for OABEmpowering-Patients-to-Continue-Treatment-for-OAB-2.pdf897 KB pdf FacebookLinkedinTHE\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.capgemini.com\/gb-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/\" \/>\n<meta property=\"og:site_name\" content=\"Capgemini UK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Capgemini\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-07T07:50:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.capgemini.com\/gb-en\/wp-content\/uploads\/sites\/5\/2022\/05\/invent-hero-13.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2250\" \/>\n\t<meta property=\"og:image:height\" content=\"1365\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/news\\\/client-stories\\\/empowering-patients-to-continue-treatment-for-oab\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/news\\\/client-stories\\\/empowering-patients-to-continue-treatment-for-oab\\\/\"},\"author\":{\"name\":\"Sai Kiran\",\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/#\\\/schema\\\/person\\\/e18c469582cc4e2dd2649041406912d2\"},\"headline\":\"Empowering patients to continue treatment for OAB\",\"datePublished\":\"2019-03-07T11:02:00+00:00\",\"dateModified\":\"2025-03-07T07:50:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/news\\\/client-stories\\\/empowering-patients-to-continue-treatment-for-oab\\\/\"},\"wordCount\":146,\"publisher\":{\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/news\\\/client-stories\\\/empowering-patients-to-continue-treatment-for-oab\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2022\\\/05\\\/invent-hero-13.png\",\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/news\\\/client-stories\\\/empowering-patients-to-continue-treatment-for-oab\\\/\",\"url\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/news\\\/client-stories\\\/empowering-patients-to-continue-treatment-for-oab\\\/\",\"name\":\"Empowering patients to continue treatment for OAB - Capgemini UK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/news\\\/client-stories\\\/empowering-patients-to-continue-treatment-for-oab\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/news\\\/client-stories\\\/empowering-patients-to-continue-treatment-for-oab\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2022\\\/05\\\/invent-hero-13.png\",\"datePublished\":\"2019-03-07T11:02:00+00:00\",\"dateModified\":\"2025-03-07T07:50:28+00:00\",\"description\":\"Client StoriesEmpowering Patients to continue treatment for OABEmpowering-Patients-to-Continue-Treatment-for-OAB-2.pdf897 KB pdf FacebookLinkedinTHE\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/news\\\/client-stories\\\/empowering-patients-to-continue-treatment-for-oab\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/news\\\/client-stories\\\/empowering-patients-to-continue-treatment-for-oab\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/news\\\/client-stories\\\/empowering-patients-to-continue-treatment-for-oab\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2022\\\/05\\\/invent-hero-13.png\",\"contentUrl\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/wp-content\\\/uploads\\\/sites\\\/5\\\/2022\\\/05\\\/invent-hero-13.png\",\"width\":2250,\"height\":1365},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/news\\\/client-stories\\\/empowering-patients-to-continue-treatment-for-oab\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Empowering patients to continue treatment for OAB\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/#website\",\"url\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/\",\"name\":\"Capgemini\",\"description\":\"Get the future you want\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/#organization\",\"name\":\"Capgemini\",\"url\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":null,\"contentUrl\":null,\"width\":null,\"height\":null,\"caption\":\"Capgemini\"},\"image\":{\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Capgemini\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/capgemini\",\"https:\\\/\\\/www.instagram.com\\\/capgemini\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/capgeminimedia\",\"https:\\\/\\\/www.glassdoor.com\\\/Overview\\\/Working-at-Capgemini-EI_IE3803.11,20.htm\"],\"description\":\"Businesses everywhere are transforming. AI and cutting-edge technologies have created a groundswell of opportunities, new sources of long-term value and resilience. Capgemini is at the heart of this new technology revolution, partnering with clients in every sector to deliver real, sustainable transformation at scale. Collaborating across multiple business and tech ecosystems, our team of 420,000 experts in more than 50 countries unleashes human energy through technology and AI for an inclusive and sustainable future. Fostering agility, leveraging creativity, and maximizing competitiveness, Capgemini is the partner of choice for the businesses and organizations of tomorrow, helping our clients unlock the value of technology that will define their success in the decades to come.\",\"legalName\":\"Capgemini\",\"foundingDate\":\"1967-10-01\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"5001\",\"maxValue\":\"10000\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/#\\\/schema\\\/person\\\/e18c469582cc4e2dd2649041406912d2\",\"name\":\"Sai Kiran\",\"url\":\"https:\\\/\\\/www.capgemini.com\\\/gb-en\\\/author\\\/saikiranb\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Empowering patients to continue treatment for OAB - Capgemini UK","description":"Client StoriesEmpowering Patients to continue treatment for OABEmpowering-Patients-to-Continue-Treatment-for-OAB-2.pdf897 KB pdf FacebookLinkedinTHE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.capgemini.com\/gb-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/","og_locale":"en_GB","og_type":"article","og_title":"Empowering patients to continue treatment for OAB","og_description":"Client StoriesEmpowering Patients to continue treatment for OABEmpowering-Patients-to-Continue-Treatment-for-OAB-2.pdf897 KB pdf FacebookLinkedinTHE","og_url":"https:\/\/www.capgemini.com\/gb-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/","og_site_name":"Capgemini UK","article_publisher":"https:\/\/www.facebook.com\/Capgemini\/","article_modified_time":"2025-03-07T07:50:28+00:00","og_image":[{"width":2250,"height":1365,"url":"https:\/\/www.capgemini.com\/gb-en\/wp-content\/uploads\/sites\/5\/2022\/05\/invent-hero-13.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.capgemini.com\/gb-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/#article","isPartOf":{"@id":"https:\/\/www.capgemini.com\/gb-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/"},"author":{"name":"Sai Kiran","@id":"https:\/\/www.capgemini.com\/gb-en\/#\/schema\/person\/e18c469582cc4e2dd2649041406912d2"},"headline":"Empowering patients to continue treatment for OAB","datePublished":"2019-03-07T11:02:00+00:00","dateModified":"2025-03-07T07:50:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.capgemini.com\/gb-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/"},"wordCount":146,"publisher":{"@id":"https:\/\/www.capgemini.com\/gb-en\/#organization"},"image":{"@id":"https:\/\/www.capgemini.com\/gb-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/#primaryimage"},"thumbnailUrl":"https:\/\/www.capgemini.com\/gb-en\/wp-content\/uploads\/sites\/5\/2022\/05\/invent-hero-13.png","inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/www.capgemini.com\/gb-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/","url":"https:\/\/www.capgemini.com\/gb-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/","name":"Empowering patients to continue treatment for OAB - Capgemini UK","isPartOf":{"@id":"https:\/\/www.capgemini.com\/gb-en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.capgemini.com\/gb-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/#primaryimage"},"image":{"@id":"https:\/\/www.capgemini.com\/gb-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/#primaryimage"},"thumbnailUrl":"https:\/\/www.capgemini.com\/gb-en\/wp-content\/uploads\/sites\/5\/2022\/05\/invent-hero-13.png","datePublished":"2019-03-07T11:02:00+00:00","dateModified":"2025-03-07T07:50:28+00:00","description":"Client StoriesEmpowering Patients to continue treatment for OABEmpowering-Patients-to-Continue-Treatment-for-OAB-2.pdf897 KB pdf FacebookLinkedinTHE","breadcrumb":{"@id":"https:\/\/www.capgemini.com\/gb-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.capgemini.com\/gb-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.capgemini.com\/gb-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/#primaryimage","url":"https:\/\/www.capgemini.com\/gb-en\/wp-content\/uploads\/sites\/5\/2022\/05\/invent-hero-13.png","contentUrl":"https:\/\/www.capgemini.com\/gb-en\/wp-content\/uploads\/sites\/5\/2022\/05\/invent-hero-13.png","width":2250,"height":1365},{"@type":"BreadcrumbList","@id":"https:\/\/www.capgemini.com\/gb-en\/news\/client-stories\/empowering-patients-to-continue-treatment-for-oab\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.capgemini.com\/gb-en\/"},{"@type":"ListItem","position":2,"name":"Empowering patients to continue treatment for OAB"}]},{"@type":"WebSite","@id":"https:\/\/www.capgemini.com\/gb-en\/#website","url":"https:\/\/www.capgemini.com\/gb-en\/","name":"Capgemini","description":"Get the future you want","publisher":{"@id":"https:\/\/www.capgemini.com\/gb-en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.capgemini.com\/gb-en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/www.capgemini.com\/gb-en\/#organization","name":"Capgemini","url":"https:\/\/www.capgemini.com\/gb-en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.capgemini.com\/gb-en\/#\/schema\/logo\/image\/","url":null,"contentUrl":null,"width":null,"height":null,"caption":"Capgemini"},"image":{"@id":"https:\/\/www.capgemini.com\/gb-en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Capgemini\/","https:\/\/www.linkedin.com\/company\/capgemini","https:\/\/www.instagram.com\/capgemini\/","https:\/\/www.youtube.com\/user\/capgeminimedia","https:\/\/www.glassdoor.com\/Overview\/Working-at-Capgemini-EI_IE3803.11,20.htm"],"description":"Businesses everywhere are transforming. AI and cutting-edge technologies have created a groundswell of opportunities, new sources of long-term value and resilience. Capgemini is at the heart of this new technology revolution, partnering with clients in every sector to deliver real, sustainable transformation at scale. Collaborating across multiple business and tech ecosystems, our team of 420,000 experts in more than 50 countries unleashes human energy through technology and AI for an inclusive and sustainable future. Fostering agility, leveraging creativity, and maximizing competitiveness, Capgemini is the partner of choice for the businesses and organizations of tomorrow, helping our clients unlock the value of technology that will define their success in the decades to come.","legalName":"Capgemini","foundingDate":"1967-10-01","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"5001","maxValue":"10000"}},{"@type":"Person","@id":"https:\/\/www.capgemini.com\/gb-en\/#\/schema\/person\/e18c469582cc4e2dd2649041406912d2","name":"Sai Kiran","url":"https:\/\/www.capgemini.com\/gb-en\/author\/saikiranb\/"}]}},"brand_term":[],"archive_status":false,"featured_image_src":"https:\/\/www.capgemini.com\/gb-en\/wp-content\/uploads\/sites\/5\/2022\/05\/invent-hero-13.png","featured_image_alt":"","jetpack_sharing_enabled":true,"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"Capgemini UK","distributor_original_site_url":"https:\/\/www.capgemini.com\/gb-en","push-errors":false,"featured_image_url":"https:\/\/www.capgemini.com\/gb-en\/wp-content\/uploads\/sites\/5\/2022\/05\/invent-hero-13.png","_links":{"self":[{"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/client-story\/541244","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/client-story"}],"about":[{"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/types\/client-story"}],"author":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/users\/103"}],"version-history":[{"count":6,"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/client-story\/541244\/revisions"}],"predecessor-version":[{"id":681460,"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/client-story\/541244\/revisions\/681460"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/media\/541247"}],"wp:attachment":[{"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/media?parent=541244"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/tags?post=541244"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/brand?post=541244"},{"taxonomy":"service","embeddable":true,"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/service?post=541244"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/industry?post=541244"},{"taxonomy":"partners","embeddable":true,"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/partners?post=541244"},{"taxonomy":"country","embeddable":true,"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/country?post=541244"},{"taxonomy":"content-group","embeddable":true,"href":"https:\/\/www.capgemini.com\/gb-en\/wp-json\/wp\/v2\/content-group?post=541244"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}